Please provide your email address to receive an email when new articles are posted on . In patients with psoriatic arthritis, secukinumab and adalimumab demonstrated similar results regarding ...

The severity of enthesitis in psoriatic arthritis is a potential marker for severe disease and joint damage, a cross-sectional study found. For instance, a 10-unit increase on the Madrid Sonographic ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The approval was based on data from the 2-year phase 3 JUNIPERA study that evaluated secukinumab in pediatric patients aged 2 to 17 years with a confirmed diagnosis of ERA or JPsA. The Food and Drug ...

VIENNA — The investigational interleukin (IL)-17 inhibitor izokibep hit its mark when it came to improving overall disease activity in people with active psoriatic arthritis (PsA) in a phase 2b/3 ...

Juvenile idiopathic arthritis (JIA) encompasses a group of pediatric inflammatory arthritides that includes oligoarticular JIA, polyarticular JIA, systemic JIA, psoriatic JIA, and enthesitis-related ...

Psoriatic arthritis (PsA), a heterogeneous, chronic inflammatory disorder that can involve peripheral joints, entheses, and the axial skeleton, is more common in patients with psoriasis. Approximately ...

If FDA approved for children, secukinumab (Cosentyx) will be the first biologic treatment for children in the US living with enthesitis-related arthritis. Results from the phase III JUNIPERA study ...

Risk factors for the development of inflammatory bowel disease (IBD) among patients with juvenile idiopathic arthritis (JIA) included the subtype of JIA, family history, and medication use, a large ...

The approval was based on data from 2 pivotal phase 3 studies, which compared Skyrizi to placebo in adults with active PsA who had an inadequate response or were intolerant to biologic therapy and/or ...

Psoriatic arthritis happens when your immune system mistakenly attacks healthy cells in your body. (About 1.5 million 2 people in America have psoriatic arthritis.) If you are trying to determine ...